Physician

Douglas Edward Mazzuca, D.O.

According to 2025 Medicare claims, Douglas Mazzuca, D.O. (NPI: 1720348931) practices ophthalmology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. This provider's primary affiliated billing organization is MAZZUCA EYE AND LASER CENTERS,PA (NPI: 1942255831; TIN: 223485583) and primary practice location at 08070-1754.

Mazzuca's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 948 traditional Medicare patients, billed 3,962 HCPCS/CPT codes, and received $342,834 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,359 prescription claims across 575 beneficiaries totaling $338,807 in drug costs, led by Lumigan (Bimatoprost). DME data shows 167 claims. Open Payments data shows 21 records totaling $618. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,930 to $338,807. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	575	1,795	$142,477
2017	1,010	4,036	$373,812
2018	1,025	3,939	$387,036
2019	914	3,663	$413,535
2020	764	3,029	$315,584
2021	1,001	3,590	$377,414
2022	1,039	4,026	$390,888
2023	1,007	3,956	$392,092
2024	948	3,962	$342,834

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	42	$3,930
2016	99	202	$16,850
2017	368	1,403	$136,681
2018	409	1,474	$169,479
2019	345	1,540	$229,220
2020	374	1,801	$223,505
2021	489	2,447	$327,393
2022	548	3,140	$393,789
2023	544	3,208	$408,950
2024	575	3,359	$338,807

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	155	155	$10,294
2019	352	354	$23,312
2020	252	253	$15,162
2021	295	295	$17,902
2022	354	354	$21,498
2023	283	283	$15,785
2024	167	167	$11,152

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	665	719	$91
92012	Established patient problem focused exam of visual system	407	707	$65
92083	Exam of visual field with extended testing	206	216	$44
92250	Photography of the retina	184	190	$27
92133	Imaging of optic nerve	219	230	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	177	8,970	$78,057
Restasis	Cyclosporine	56	2,280	$46,405
Rocklatan	Netarsudil Mesylat/Latanoprost	56	2,105	$23,894
Combigan	Brimonidine Tartrate/Timolol	81	2,680	$20,070
Xiidra	Lifitegrast	23	750	$16,805

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	51	51	$2,811
V2319	Trifocal seg width over 28 mm	N	23	23	$2,405
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	20	20	$2,187
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	19	19	$2,145
V2755	U-v lens, per lens	N	54	54	$1,603

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$618	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Douglas Edward Mazzuca, D.O.?

Tedicare shows public-source Medicare data for Douglas Edward Mazzuca, D.O. (NPI 1720348931), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Douglas Edward Mazzuca, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Douglas Edward Mazzuca, D.O.?

Douglas Edward Mazzuca, D.O. is linked to MAZZUCA EYE AND LASER CENTERS,PA (billing NPI 1942255831) in the available physician profile data.

Does Douglas Edward Mazzuca, D.O. have Open Payments data?

Douglas Edward Mazzuca, D.O. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.